Bharat Biotech on Wednesday announced its Covid-19 vaccine candidate BBV152 Covaxin demonstrated 81% interim vaccine efficacy in its Phase 3 clinical trial. Original source: https://health.economictimes.indiatimes.com/news/pharma/81329879?utm_source=RSS&utm_medium=ETRSS
Pharma Reviews
A dietary supplement manufacturer and two of its executives have been ordered by a federal court to stop manufacturing, holding, or distributing any articles of…
FDA alerted users of thermal imaging systems intended to measure body temperature that improper use of the systems may provide inaccurate temperature readings. FDA also…
The FDA is alerting consumers, health care providers and users that improper use of thermal imaging devices may provide inaccurate temperature readings. Original source: http://www.fda.gov/medical-devices/safety-communications/improper-use-thermal-imaging-devices-fda-safety-communication
Vibcare Pharma – Assistant – Sales (0-1 yrs) Chandigarh/Haryana (Channel Sales) which suit their requirement- Good communication, comprehension and management skillsExperience in Sales and Pharma…
Pharma Assistant – Hospital – B.Pharma (2-3 yrs) Madurai (Pharma Covigilance & Drug Safety) – Have proper certification as B.Pharma, should have min 1 year…
Analyst-Pharma ERP Job Description Skill required: Pharma ERP – SDTM (Study Data Tabulation Model) Mapping Designation: Management Level… to l Job Description Skill required: Pharma…
Unlike the Covid-19 vaccines currently in use, which use a new technology involving messenger RNA, the Johnson & Johnson vaccine utilizes a method that has…
The new vaccine differs markedly from the two already in use in the United States. Here is how they compare. Original source: https://health.economictimes.indiatimes.com/news/pharma/81268054?utm_source=RSS&utm_medium=ETRSS
The trials involved 25,800 participants and was conducted in partnership with the Indian government’s medical research body. Original source: https://health.economictimes.indiatimes.com/news/pharma/81311876?utm_source=RSS&utm_medium=ETRSS